| __timestamp | Pfizer Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 14097000000 | 381287000 |
| Thursday, January 1, 2015 | 14809000000 | 452612000 |
| Friday, January 1, 2016 | 14837000000 | 316800000 |
| Sunday, January 1, 2017 | 14784000000 | 330100000 |
| Monday, January 1, 2018 | 14455000000 | 265800000 |
| Tuesday, January 1, 2019 | 14350000000 | 336200000 |
| Wednesday, January 1, 2020 | 11615000000 | 423900000 |
| Friday, January 1, 2021 | 12703000000 | 467000000 |
| Saturday, January 1, 2022 | 13677000000 | 487000000 |
| Sunday, January 1, 2023 | 14771000000 | 477100000 |
| Monday, January 1, 2024 | 14730000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical landscape, understanding the financial strategies of industry leaders is crucial. Over the past decade, Pfizer Inc. and United Therapeutics Corporation have showcased distinct trends in their Selling, General, and Administrative (SG&A) expenses. Pfizer, a global behemoth, consistently reported SG&A expenses averaging around $14 billion annually, with a notable dip in 2020, reflecting a strategic shift or market adaptation. In contrast, United Therapeutics, a more niche player, maintained a steady increase, peaking at nearly $487 million in 2022, marking a 30% rise from 2014. This divergence highlights Pfizer's expansive operational scale compared to United Therapeutics' focused growth strategy. As the pharmaceutical sector continues to innovate, these financial insights offer a window into the strategic priorities and market positioning of these two influential companies.
Revenue Showdown: Pfizer Inc. vs United Therapeutics Corporation
Pfizer Inc. and Viatris Inc.: SG&A Spending Patterns Compared
Pfizer Inc. and Sarepta Therapeutics, Inc.: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Pfizer Inc. and Walgreens Boots Alliance, Inc.
Pfizer Inc. or BioCryst Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: United Therapeutics Corporation vs BioMarin Pharmaceutical Inc.
Who Optimizes SG&A Costs Better? United Therapeutics Corporation or Alpine Immune Sciences, Inc.
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Apellis Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Rhythm Pharmaceuticals, Inc.
United Therapeutics Corporation or HUTCHMED (China) Limited: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: United Therapeutics Corporation vs MiMedx Group, Inc.
Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Evotec SE